Latest Insider Transactions at Xeris Biopharma Holdings, Inc. (XERS)
This section provides a real-time view of insider transactions for Xeris Biopharma Holdings, Inc. (XERS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Xeris Biopharma Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Xeris Biopharma Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 03
2024
|
John Patrick Shannon Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
40,834
-1.76%
|
$81,668
$2.24 P/Share
|
|
Nov 27
2023
|
Jeffrey W Sherman Director |
BUY
Open market or private purchase
|
Indirect |
5,400
+50.0%
|
$5,400
$1.87 P/Share
|
|
Nov 20
2023
|
Dawn Halkuff Director |
BUY
Open market or private purchase
|
Indirect |
5,410
+50.0%
|
$5,410
$1.84 P/Share
|
|
Nov 20
2023
|
Steven Pieper Officer |
BUY
Open market or private purchase
|
Direct |
28,000
+2.32%
|
$28,000
$1.95 P/Share
|
|
Nov 17
2023
|
John Patrick Shannon Jr Director |
BUY
Open market or private purchase
|
Direct |
30,769
+2.14%
|
$30,769
$1.64 P/Share
|
|
Nov 16
2023
|
John P. Schmid Director |
BUY
Open market or private purchase
|
Indirect |
6,500
+50.0%
|
$6,500
$1.51 P/Share
|
|
Nov 14
2023
|
Marla Persky Director |
BUY
Open market or private purchase
|
Indirect |
6,370
+50.0%
|
$6,370
$1.58 P/Share
|
|
Aug 09
2023
|
Paul R Edick Director |
BUY
Open market or private purchase
|
Direct |
10,000
+0.44%
|
$20,000
$2.38 P/Share
|
|
Jul 28
2023
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,200
-0.64%
|
$20,400
$2.53 P/Share
|
|
Jun 07
2023
|
Garheng Kong Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+28.3%
|
-
|
|
Jun 07
2023
|
Barbara Jean Anne Bormann Kennedy Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+42.5%
|
-
|
|
Jun 07
2023
|
John P. Schmid Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+40.22%
|
-
|
|
Jun 07
2023
|
Marla Persky Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+42.5%
|
-
|
|
Jun 07
2023
|
Dawn Halkuff Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+42.5%
|
-
|
|
Jun 07
2023
|
John Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+7.35%
|
-
|
|
Jun 07
2023
|
Jeffrey W Sherman Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+28.26%
|
-
|
|
Mar 27
2023
|
Ricki Louise Fairley Director |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+50.0%
|
-
|
|
Jan 31
2023
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
778
-0.05%
|
$778
$1.24 P/Share
|
|
Jan 31
2023
|
Kenneth Erland Johnson Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,393
-0.82%
|
$3,393
$1.24 P/Share
|
|
Jan 31
2023
|
Beth Hecht Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,784
-0.39%
|
$5,784
$1.24 P/Share
|
|
Jan 31
2023
|
John Patrick Shannon Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
9,880
-0.42%
|
$9,880
$1.24 P/Share
|
|
Jan 31
2023
|
Kenneth Erland Johnson Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+27.04%
|
-
|
|
Jan 31
2023
|
Beth Hecht Officer |
BUY
Grant, award, or other acquisition
|
Direct |
350,000
+30.49%
|
-
|
|
Jan 31
2023
|
Steven Prestrelski Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+17.25%
|
-
|
|
Jan 31
2023
|
Steven Pieper Officer |
BUY
Grant, award, or other acquisition
|
Direct |
750,000
+39.5%
|
-
|
|
Jan 31
2023
|
Paul R Edick Director |
BUY
Grant, award, or other acquisition
|
Direct |
750,000
+24.77%
|
-
|
|
Jan 31
2023
|
John Patrick Shannon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
750,000
+35.25%
|
-
|
|
Jan 29
2023
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,590
-0.23%
|
$3,590
$1.26 P/Share
|
|
Jan 29
2023
|
Kenneth Erland Johnson Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,029
-2.59%
|
$11,029
$1.26 P/Share
|
|
Jan 29
2023
|
Beth Hecht Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,177
-1.41%
|
$21,177
$1.26 P/Share
|
|
Jan 29
2023
|
John Patrick Shannon Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
23,414
-0.99%
|
$23,414
$1.26 P/Share
|
|
Jan 03
2023
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,067
-1.43%
|
$23,067
$1.12 P/Share
|
|
Jan 03
2023
|
Kenneth Erland Johnson Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,400
-2.83%
|
$12,400
$1.12 P/Share
|
|
Jan 03
2023
|
Beth Hecht Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,488
-2.17%
|
$33,488
$1.12 P/Share
|
|
Jan 03
2023
|
John Patrick Shannon Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
41,334
-1.72%
|
$41,334
$1.12 P/Share
|
|
Dec 13
2022
|
Paul R Edick Director |
BUY
Open market or private purchase
|
Direct |
20,000
+1.29%
|
$20,000
$1.45 P/Share
|
|
Jul 28
2022
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,767
-0.6%
|
$9,767
$1.43 P/Share
|
|
Jun 08
2022
|
John Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+2.95%
|
-
|
|
Jun 08
2022
|
John P. Schmid Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+42.07%
|
-
|
|
Jun 08
2022
|
Dawn Halkuff Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Jun 08
2022
|
Marla Persky Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Jun 08
2022
|
Barbara Jean Anne Bormann Kennedy Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
$30,000
$2.1 P/Share
|
|
Jun 08
2022
|
Jeffrey W Sherman Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+18.66%
|
-
|
|
Jun 08
2022
|
Garheng Kong Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+18.71%
|
-
|
|
May 12
2022
|
Paul R Edick Director |
BUY
Open market or private purchase
|
Direct |
100,000
+6.22%
|
$100,000
$1.4 P/Share
|
|
Feb 22
2022
|
Steven Prestrelski Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
11,228
-1.93%
|
$22,456
$2.42 P/Share
|
|
Feb 22
2022
|
Steven Prestrelski Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,228
+1.9%
|
$0
$0.69 P/Share
|
|
Jan 31
2022
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
750
-0.05%
|
$1,500
$2.11 P/Share
|
|
Jan 31
2022
|
Kenneth Erland Johnson Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,307
-0.52%
|
$4,614
$2.11 P/Share
|
|
Jan 31
2022
|
Beth Hecht Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,448
-0.29%
|
$8,896
$2.11 P/Share
|